Behind every treatment that improves human health is a story of discovery. At the Monash Biomedicine Discovery Institute we are making the discoveries that will relieve the future burden of disease. We do this by tackling the big research questions that address the underlying causes of major global health issues.
The Monash Biomedicine Discovery Institute (BDI) brings together more than 120 research teams from multiple disciplines into six global health priority areas. Our six Discovery Programs are Cancer, Cardiovascular Disease, Development and Stem Cells, Infection and Immunity, Metabolism, Diabetes and Obesity, and Neuroscience.
But tackling the big questions in biomedical research demands new perspectives to find new solutions. Spanning six Discovery Programs, we are one of the largest and highest- quality biomedical research institutes in Australia. This allows for the cross-pollination of ideas as it is at the intersection of these global health issues that truly innovative discoveries will be made.
Our exceptional research is possible because our scientists are led by internationally-renowned researchers and they have access to truly world-class technology and infrastructure.
Discoveries will only lead to better health if we partner with the most innovative companies and the best clinical scientists. We have a well-developed record of working with major pharmaceutical companies and a number of our researchers have successfully developed drugs for clinical use. The Monash BDI is at the heart of one of the largest – and fastest growing – medical research hubs in Australia thanks to our relationships with Monash Partners and the Monash Academic Health Science Centre.
Research has no borders and requires an international outlook to be competitive with the best in the world. We encourage strong international networks and partnerships in research and research training, and our scientists have more than 200 productive international collaborations.
Training the next generation of scientists is central to what we do and we have close to 270 PhD students carrying out research projects at any one time. Our graduate programs provide outstanding career development opportunities including training in industry engagement, commercialisation and entrepreneurship.
Combining our commitment to outstanding research with our capacity to engage both clinicians and industry means we are well placed to fulfil our aim of having an impact on global health. Please get in touch if you’d like to help us make the next big discovery.
Best wishes, John